Document:

Exhibit 10.3

 

 

 

IMPORTANT: PLEASE READ CAREFULLY
BEFORE SIGNING

SIGNIFICANT REPRESENTATIONS ARE CALLED
FOR HEREIN

 

 

LETTER OF INVESTMENT INTENT

 

The undersigned hereby
submits this Letter of Investment Intent in connection with the amendment and restatement of the Simple Interest Commercial Promissory
Note issued by Cryoport Systems, Inc. to the undersigned (“Original Note”) as further described on the signature page
hereof, the form of such amendment and restatement is attached hereto as Exhibit A (such amended and restated promissory
note, the “Note”), and the issuance of a Warrant in the form attached hereto as Exhibit B for the purchase
of a certain number of shares of Common Stock of Cryoport, Inc. (the “Company”) at an exercise price of $0.50
per share (the “Warrant”), upon the terms and conditions set forth below. The number of shares that will be
issuable upon exercise of the Warrant will equal the outstanding principal balance of the Note. In addition, the Company shall
issue the undersigned a warrant (“Fee Warrant”) to purchase _____ shares of Common Stock of the Company in the form
attached hereto as Exhibit C to reimburse the undersigned for any fees or other expenses incurred in connection with this
transaction. Collectively the Note, Warrant and the Fee Warrant are hereinafter referred to as the “Securities”.

 

By execution below,
the undersigned acknowledges that the Company is relying upon the accuracy and completeness of the representations contained herein
in complying with its obligations under applicable securities laws.

 

		1.	Transaction.

 

		(a)	Concurrently herewith, the undersigned agrees to amend and restate the Original Note and accept
the Warrant and the Fee Warrant as consideration for accepting the Note.

 

		(b)	THE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS
OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.
THE ACQUISITION OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK
OF THE LOSS OF THEIR ENTIRE INVESTMENT.

 

		2.	Representations. The undersigned acknowledges and represents as follows:

 

		(a)	The undersigned has received, and is familiar with the Securities, and the publicly available filings
by the Company with the Securities Exchange Commission (collectively the “Disclosure Documents”).

 

    	 

    	 

    

 

		(b)	The undersigned is in a financial position to hold the Securities for an indefinite period of time
and is able to bear the economic risk and withstand a complete loss of its investment in the Securities.

 

		(c)	The undersigned believes it, either alone or with the assistance of its professional advisor, has
such knowledge and experience in financial and business matters that it is capable of reading and interpreting the Disclosure Documents
and evaluating the merits and risks of the prospective investment in the Securities and has the net worth to undertake such risks.

 

		(d)	The undersigned has obtained, to the extent it deems necessary, professional advice with respect
to the risks inherent in the investment in the Securities, and the suitability of the investment in the Securities in light of
its financial condition and investment needs.

 

		(e)	The undersigned believes that the investment in the Securities is suitable for it based upon its
investment objectives and financial needs, and the undersigned has adequate means for providing for its current financial needs
and contingencies and has no need for liquidity of investment with respect to the Securities.

 

		(f)	The undersigned understands that no public market for the Securities exists, or is likely to develop,
and that it may not be possible to liquidate this investment readily, if at all, in the case of an emergency or for any other reason.

 

		(g)	The undersigned recognizes that an investment in the Securities involves a high degree of risk.

 

		(h)	The undersigned realizes that (1) the Securities and the shares into which they may be exchanged
is a long-term investment, (2) the undersigned must bear the economic risk of investment for an indefinite period of time because
the Securities and any such shares that may be issued upon exercise of the Warrant will not have been registered under the Securities
Act of 1933 and, therefore, cannot be sold unless they are subsequently registered under said Act or an exemption from such registration
is available and (3) the transferability of the Securities and such shares is restricted pending effectiveness of such a registration
of qualification for an exemption.

 

		(i)	The undersigned has been advised that the offering and issuance of Securities or shares of the
Compnay’s common stock issuable on conversion or exercise thereof will not be registered under the Securities Act of 1933
or the relevant state securities laws but are being offered and issued pursuant to exemptions from such laws and that the Company’s
reliance upon such exemptions is predicated in part on the undersigned’s representations as contained herein. The undersigned
represents and warrants that the Securities are being acquired for the undersigned’s own account and for investment and without
the intention of reselling or redistributing the same, that it has made no agreement with others regarding any of such Securities
and that its financial condition is such that it is not likely that it will be necessary to dispose of any of the Securities in
the foreseeable future.

 

		(j)	The undersigned represents and warrants that it is a bona fide resident of, and is domiciled in
the state indicated on the signature page below under “Address”, and that the Securities are being acquired by it in
its name solely for its own beneficial interest and not as nominee for, or on behalf of, or for the beneficial interest of, or
with the intention to transfer to, any other person, trust or organization.

 

    	2

    	 

    

 

		(k)	The undersigned understands that the representations contained below are made for the purpose of
qualifying it is an “accredited investor” as that term is defined in Regulation D of the General Rules and Regulations
under the Securities Act of 1933 and for the purpose of inducing a sale of securities to it. The undersigned hereby represents
that the statement or statements initialled below are true and correct in all respects. The undersigned understands that a false
representation may constitute a violation of law, and that any person who suffers damage as a result of a false representation
may have a claim against the undersigned for damages.

 

		(l)	The undersigned understands that certificates evidencing the Securities may bear the following
or any similar legend (in addition to any other legends that may be required):

 

			(i) “THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED,
OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE SOLD OR OFFERED FOR SALE IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES OR AN OPINION OF COUNSEL OR OTHER EVIDENCE ACCEPTABLE TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

			(ii) If required by the authorities of any state in connection with the issuance of sale of the
Securities, the legend required by such state authority.

 

		(m)	The undersigned represents and warrants that it did not learn of the investment in the Securities
as a result of any general solicitation or general advertising.

 

		(n)	Since the date on which undersigned first learned about the investment opportunity, the undersigned
has not disclosed any information regarding such opportunity to any third parties (other than its affiliates and legal, accounting
and other advisors who are bound by agreements or duties of confidentiality) and has not engaged in any purchases or sales involving
the securities of the Company (including, without limitation, any short sales involving the Company’s securities). The undersigned
agrees that it will not engage in any purchases or sales involving the securities of the Company (including short sales) prior
to the time that the transactions contemplated by this Agreement are publicly disclosed. The undersigned agrees that it will not
use any of the Securities acquired pursuant to this Letter of Investment Intent to cover any short position in the Common Stock
if doing so would be in violation of applicable securities laws. For purposes hereof, “short sales” include, without
limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the 1934 Act,
whether or not against the box, and all types of direct and indirect stock pledges, forward sales contracts, options, puts, calls,
short sales, swaps, “put equivalent positions” (as defined in Rule 16a-1(h) under the 1934 Act) and similar arrangements
(including on a total return basis), and sales and other transactions through non-US broker dealers or foreign regulated brokers.

 

    	3

    	 

    

 

		(o)	The undersigned acknowledges that prior to acquiring the Securities, the undersigned has been provided
with financial and other written information about the Company, including the Disclosure Documents. The undersigned has been given
the opportunity by the Company to obtain such information and ask such questions concerning the Company, the Securities and the
undersigned’s investment as the undersigned felt necessary, and to the extent the undersigned took such opportunity, the
undersigned received satisfactory information and answers. If the undersigned requested any additional information which the Company
possessed or could acquire without unreasonable effort or expense which was necessary to verify the accuracy of the financial and
other written information furnished to the undersigned by the Company, such additional information was provided to the undersigned
and was satisfactory.

 

3.Accredited Investor Status.
The undersigned is an “accredited investor” within the meaning of Regulation D promulgated under the Securities Act
of 1933, as amended (the “Act”). The specific category or categories of “accredited investor” applicable
to the undersigned are as follows:

 

		(a)	Accredited individual investors must initial either or both of the following
two statements:

 

		_____ (1)	I certify that I am an accredited investor because I
had individual income (exclusive of any income attributable to my spouse) of more than $200,000 in each of the most recent two
years or joint income with my spouse of more than $300,000 in each of such years and I reasonably expect to have an individual
income in excess of such amounts for the current year.

 

		_____ (2)	I certify that I am an accredited investor because I
have an individual net worth, or my spouse and I have a combined individual net worth, in excess of $1,000,000. For purposes of
this questionnaire, “net worth” excludes the equity in my or our primary residence.

 

		(b)	Accredited partnerships, corporations or other entities must initial one or more
of the following statements, and must initial the last statement:

 

		______ (1)	The undersigned hereby certifies that all of the beneficial
equity owners of the undersigned qualify as accredited individual investors under items (a)(1) or (a)(2) above. (Those attempting
to qualify under this item may be required to provide additional information beyond the equity owner of the entity.)

 

		______ (2)	The undersigned is a bank or savings and loan association
as defined in Sections 3(a)(2) and 3(a)(5)(A), respectively, of the Act acting either in its individual or fiduciary capacity.

  

		______ (3)	The undersigned is an insurance company as defined in
Section 2(a)(13) of the Act.

 

    	4

    	 

    

 

		______ (4)	The undersigned is an investment company registered under
the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that act.

 

		______ (5)	The undersigned is a trust with total assets in excess
of $5,000,000, not formed for the specific purpose of acquiring the Securities, and the undersigned is directed by a sophisticated
person as described in Rule 506(b)(2)(ii) of the Act.

 

		______ (6)	The undersigned is a private business development company
as defined in Section 202(a)(22) of the Investment Advisers Act of 1940.

 

		______ (7)	This Agreement has been duly authorized by all necessary
action on the part of the undersigned, has been duly executed by an authorized officer or representative of the undersigned, and
is a legal, valid and binding obligation of the undersigned enforceable in accordance with its terms.

 

[The remainder of this page has been intentionally
left blank.]

    	5

    	 

    

The undersigned is amending and restating
the following note:

 

Simple Interest Commercial Promissory
Note issued on or about March 1, 2005, with an original principal amount of $__________.

 

Manner in which title to the Note, Warrants and Fee Warrants
are to be held (please initial one):

 

	_____ Individual 	_____ Joint tenants with Right of Survivorship 
	 	 
	_____ Community Property 	_____ Tenants-in-Common 
	 	 
	_____ Corporation	_____ Trust
	 	 
	_____ IRA	_____ Qualified Retirement Plans
	 	 
	_____ SEP/SIMPLE	_____ LLC
	 	 
	_____ Partnership	_____ Other

  

	

IN WITNESS WHEREOF,
the undersigned has executed this Letter of Investment Intent this March 2, 2015

 

 

________________________________ 

Name: _______________

 

  

 

* * * * * * * *

 

    	6

    	 

    

 

PLEASE PRINT BELOW THE REGISTRATION

INFORMATION OF EACH INDIVIDUAL OR ENTITY
EXCHANGING

 

 

	INDIVIDUAL and JOINT	 	ENTITY
	(Please type or print name[s] exactly as it should appear on the Certificate)	 	(Please type or print name[s] exactly as it should appear on the Certificate)
	 	 	 
	 	 	 
	Name(s) Typed or Printed	 	Name Typed or Printed
	 	 	 
	 	 	 
	Daytime Phone	 	Business Phone
	 	 	 
	 	 	 
	Email Address	 	Email Address
	 	 	 
	 	 	 
	Address to Which Correspondence Should be Directed:	 	Address to Which Correspondence Should be Directed:
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	Name Person to Contact
	Social Security Number	 	 
	 	 	 
	 	 	Entity’s Taxpayer Identification Number

 

    	7

    	 

    

 

EXHIBIT A

 

NOTE

 

    	8

    	 

    

 

EXHIBIT B

 

WARRANT

 

    	9

    	 

    

 

EXHIIBIT C

 

FEE WARRANT

 

    	10Exhibit 10.4

 

THIS AMENDED AND RESTATED PROMISSORY NOTE,
AND THE SECURITIES INTO WHICH IT IS CONVERTIBLE (COLLECTIVELY, THE “SECURITIES”), HAVE NOT BEEN REGISTERED WITH
THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE. THE SECURITIES ARE BEING OFFERED
PURSUANT TO CLAIMED EXEMPTIONS FROM REGISTRATION UNDER REGULATION D PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
“ACT”). THE SECURITIES ARE “RESTRICTED SECURITIES” AND MAY NOT BE OFFERED OR RESOLD UNLESS
THE SECURITIES ARE REGISTERED UNDER THE ACT, OR ELIGIBLE TO BE OFFERED OR SOLD PURSUANT TO AN APPLICABLE EXEMPTION FROM SUCH REGISTRATION
REQUIREMENTS. THE COMPANY MAY REQUIRE THAT IT BE PROVIDED WITH OPINION OF COUNSEL OR OTHER SUCH INFORMATION AS IT MAY REASONABLY
REQUIRE TO CONFIRM THAT SUCH EXEMPTIONS ARE AVAILABLE. FURTHER, HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE MADE EXCEPT
IN COMPLIANCE WITH THE ACT.

 

CRYOPORT
SYSTEMS, INC.

 

AMENDED AND RESTATED PROMISSORY NOTE

 

US $____________

 

This Amended and Restated
Promissory Note (the “Note”) is an amendment and restatement of the Simple Interest Commercial Promissory
Note (the “Original Note”) issued on or about March 1, 2005 by Cryoport
Systems, Inc., a California corporation (the “Company”) with
in original principal balance of $____________, to _____________ (together with its permitted successors and assigns, the “Holder”)
with an address of ___________ pursuant to exemptions from registration under the Securities Act of 1933, as amended. Certain payments
were made on the Original Note and interest has accrued, which is being added to the principal amount due under the Original Note,
such that the outstanding principal amount of this Note is $______________. 

 

ARTICLE 1

 

1.1             
Principal and Interest. The Company hereby promises to pay the principal sum of US $________ pursuant to the
terms hereof and to pay interest to the Holder on such principal balance from the date hereof. From the date hereof through the
date of payment, interest shall accrue at the rate of six percent (6%) per annum.

 

1.2             
Maturity Date. All unpaid principal and accrued interest hereunder shall accelerate and become due and shall
be paid on the earlier of (a) March 1, 2016, (b) the sale of all or substantially all of the assets of the Company or Cryoport,
Inc. (“Cryoport”), or (c) the merger, consolidation or other similar reorganization of the Company or
Cryoport affiliate with another entity (the “Maturity Date”).

 

1.3             
Payments. The Company shall (a) make payments of all accrued interest on a calendar quarterly basis, with
the first such payment due June 30, 2015, and thereafter on the last day of each calendar quarter during the term of the Note,
and (b) repay all outstanding principal and any remaining unpaid accrued interest on the Maturity Date.

 

    	Page 1 of 6

    	 

    

 

1.4             
Optional Conversion.

 

1.4.1       
Qualified Offering. This Note is convertible into certain capital stock of Cryoport in accordance with the conversion
rights specified herein. In the event of a public offering by Cryoport pursuant to an effective registration statement under the
Securities Act of 1933, as amended, resulting in at least $5,000,000 of gross cash proceeds to Cryoport that is for the sale of
shares of common stock or includes the sale of shares of common stock among the sale of other securities (a “Qualified
Offering”), Cryoport shall in such event notify the Holder in writing within thirty (30) days of such Qualified Offering
of the terms of such Qualified Offering, and the Holder shall have the option until thirty (30) days after such notice to elect
in writing to convert all or a portion of the principal and accrued interest under this Note into the equity securities that were
issued by Cryoport in such Qualified Offering at the Qualified Offering Conversion Rate. The conversion pursuant to the notice
shall only be effective and concurrent with the closing of the Qualified Offering. The “Qualified Offering Conversion
Rate” shall be determined by dividing the principal and accrued interest the Holder elects to convert by the Qualified
Offering Conversion Price. The “Qualified Offering Conversion Price” shall mean eighty percent
(80%) of the price per share (or unit, if applicable) of the securities issued by Cryoport in such Qualified Offering (i.e., a
twenty percent (20%) discount). Cryoport shall not issue fractional shares upon a conversion. If the application of the Conversion
price shall contemplate issuance of less than a half share, such fractional share shall not be issued and no payment shall be made
to the converting Holder and should such application result in the issuance of a half or greater fractional share, such fractional
share shall be rounded up to the next full share.

 

1.4.2       
Example. For example, if units consisting of one share of common stock of Cryoport and a warrant to purchase one
share of common stock were issued in a Qualified Offering at a unit price of $5.00, then the Qualified Offering Conversion Price
would be $4.00, which is a 20% discount to the unit offering price. If Holder elected to convert $100,000 of principal and interest,
Holder would be issued 25,000 units, or 25,000 shares of common stock of Cryoport and a warrant to purchase 25,000 shares of common
stock of Cryoport. The warrant issued to Holder would have the same terms and conditions, including exercise price, as the warrant
issued in the Qualified Offering.

 

1.4.3       
Mechanics and Effect of Conversion. Upon a conversion of this Note, the Holder shall surrender this Note, duly endorsed,
at the principal office of the Company and (if applicable) shall execute such documents as are required to be executed in connection
with any financing (including without limitation, any Qualified Financing). Upon conversion of this Note in full, this Note shall
be cancelled, and no further amounts shall be due hereunder. Upon a partial conversion of this Note, this Note shall be cancelled,
and the Company shall issue a new Note for the remaining outstanding principal balance.

 

1.4.4       
Restricted Securities. Holder understands that the shares to be issued upon a conversion pursuant to this Section
1.4 will be issued pursuant to a claimed exemption from registration under the Act and thus the certificate for such shares
will bear a restrictive legend in substantially the following form:

 

    	Page 2 of 6

    	 

    

 

“THE SECURITIES REPRESENTED BY THIS
CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES
MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT FOR THE SECURITIES UNDER SAID ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SAID ACT.”

 

ARTICLE 2

 

2.1             
Prepayment. This Note may not be prepaid without the prior written consent of Holder.

 

ARTICLE 3

 

3.1             
Events of Default. The occurrence or existence of any one or more of the following constitutes an “Event
of Default” under this Note:

 

3.1.1       
The Company fails to pay any amount of principal or interest under this Note when due if such failure is not cured by the
Company within fifteen (15) business days following written notice by Holder to the Company of such failure.

 

3.1.2       
The Company becomes subject to any bankruptcy or other voluntary or involuntary proceeding in or out of court for the adjustment
of debtor-creditor relationships.

 

3.1.3       
The Company makes an assignment for the benefit of its creditors.

 

If an Event of Default
occurs or is continuing, all sums of principal and interest under this Note shall automatically become immediately due and payable
without notice of default, presentment, or demand for payment, protest, or notice of nonpayment or dishonor, or other notices or
demands of any kind or character.

 

3.2             
Maximum Interest. Notwithstanding any other provision of this Note or any other agreement between the Company
and Holder, nothing herein shall require the Company to pay, or the Holder to accept, interest in any amount which subjects the
holder to any penalty or forfeiture under applicable law, and in no event shall the total of all charges payable hereunder (whether
of interest or of such other charges which may or might be characterized as interest) exceed the maximum rate permitted to be charged
under applicable law.

 

ARTICLE 4

 

4.1             
Re-issuance of Note. Should the Holder elect to convert a part, but not all, of the unpaid principal amount
then owing to the Holder under this Note, then the Company shall reissue a new Note in the same form as this Note to reflect the
new principal amount and the accrued and unpaid interest which was not converted.

 

    	Page 3 of 6

    	 

    

 

4.2             
Notices. Notices regarding this Note shall be sent to the parties at the following addresses, unless a party
notifies the other parties, in writing, of a change of address:

 

If to the Holder, to the address set forth
in the preamble of this Note, above.

 

	If to the Company:	Cryoport Systems, Inc.
	 	20382 Barents Sea Circle
	 	Lake Forest, CA 92101

  

4.3             
Governing Law; Jurisdiction. This Note shall be deemed to be made under and shall be construed in accordance
with the laws of the State of Nevada without giving effect to the principals of conflict of laws thereof. Any party bringing a
legal action or other proceeding against any other party arising out of or relating to this Note shall only bring the legal action
or other proceeding in the United States District Court for the Central District of California or in any court of the State of
California in County of Orange, and the parties hereby agree and submit to the personal jurisdiction and venue thereof.

 

4.4             
Severability. The invalidity of any of the provisions of this Note shall not invalidate or otherwise affect
any of the other provisions of this Note, which shall remain in full force and effect.

 

4.5             
Entire Agreement and Amendments. The effect of this Note is to amend and restate the Original Note. This Note
shall constitute a renewal, extension and modification of the terms of the Original Note and evidences the same indebtedness that
existed under the Original Note. This Note represents the entire agreement between the parties hereto with respect to the
subject matter hereof and there are no representations, warranties or commitments, except as set forth herein. This Note may be
amended only by an instrument in writing executed by the parties hereto.

 

4.6             
No Waiver, Cumulative Remedies. No failure to exercise and no delay in exercising, on the part any party,
any right, remedy, power or privilege hereunder, shall operate as a waiver thereof, nor shall any single or partial exercise of
any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right,
remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exhaustive of any
rights, remedies, powers and privileges provided by law.

 

4.7             
Attorneys’ Fees. In the event any legal action or other proceeding is brought by one party against the
other party to enforce any provision of this Note or in which the subject matter of such legal action or other proceeding arises
under, or is with respect to, the provisions of this Note, the prevailing party in any such legal action or other proceeding is
entitled to recover from the other party attorneys’ fees and costs associated with defending or prosecuting such legal action
or other proceeding, any appeal therefrom, and any ancillary or related proceedings.

 

    	Page 4 of 6

    	 

    

 

4.8             
Waiver of Trial by Jury. To the extent permitted by applicable Law, each of the parties irrevocably waives
all right of trial by jury in any action, proceeding or counterclaim arising out of or in connection with this Note or any matter
arising hereunder.

 

4.9             
Legal Holidays. In any case where the date on which any payment is due to any Holder shall not be a business
day, then any such payment need not be made on such date, but may be made on the next succeeding business day with the same force
and effect as if made on the date on which nominally due, and no interest shall accrue for the period from and after any such nominal
date.

 

[The remainder of this page has been intentionally
left blank.]

 

    	Page 5 of 6

    	 

    

 

IN WITNESS
WHEREOF, with the intent to be legally bound hereby, the parties have executed this amendment and restatement of the Note
as of March __, 2015.

 

	 	CRYOPORT, INC.
	 	 	 
	 	By: 	 
	 	Name:  	Robert Stefanovich
	 	Its:	Chief Financial Officer

	 	 	 
	 	CRYOPORT SYSTEMS, INC.
	 	 	 
	 	By: 	 
	 	Name:   	Robert Stefanovich
	 	Its:  	Chief Financial Officer 
	 	 	 
	 	HOLDER
	 	 	 
	 	 
	 	 

 

    	Page 6 of 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00241-of-00352.parquet"}]]